BOSTON SCIENTIFIC CORPORATION Gain (Loss) on Sale of Properties
BOSTON SCIENTIFIC CORPORATION (BSX) reported Gain (Loss) on Sale of Properties of $19.00 million for the 9-month period ending 2013-09-30, per its 10-Q filed 2014-11-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:GainLossOnSaleOfProperties · last filed 2014-11-05
- BOSTON SCIENTIFIC CORPORATION gain (loss) on sale of properties for the quarter ending 2013-09-30 was $0.00.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on sale of properties for the quarter ending 2013-06-30 was $0.00.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on sale of properties for the quarter ending 2013-03-31 was $19.00M.
| Period end | Gain (Loss) on Sale of Properties 3 month | Gain (Loss) on Sale of Properties 6 month | Gain (Loss) on Sale of Properties 9 month |
|---|---|---|---|
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $0.00 derived: sum of 2 quarters · filed 2014-11-05 | $19.00M 10-Q · filed 2014-11-05 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $19.00M 10-Q · filed 2014-08-06 | |
| 2013-03-31 | $19.00M 10-Q · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |